Accessibility Statement Skip Navigation
  • Resources
  • Data Privacy
  • Contact Us
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Partnerships
    • Media Inquiries
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • All Multimedia

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Accessories
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High-Tech Security
      • Internet Technology
      • Nanotechnology
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Projections or Forecasts
      • Financing Agreements
      • Insurance
      • Investment Options
      • Joint Ventures
      • Mutual Funds
      • Offerings
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing/marketing agreements
      • New Products & Services
      • Obituary
      • Outsourcing Businesses
      • Overseas Real Estate (Non-US)
      • Personnel Announcements
      • Residential Real Estate
      • Small-Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Accessories
      • Computer Electronics
      • Computer Hardware
      • Computer Networks
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Design Automation
      • Financial Technology
      • Mobile Devices/Apps
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Natural Gas Utilities
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Computer Accessories
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Computer Accessories
      • Computer Networks
      • Mobile Devices/Apps
      • Telecommunications
      • Telecommunications Carriers & Services
      • Telecommunications Equipment
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wine & Spirits
      • Beverages
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art, Culture & Design
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infectious Disease Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental Products & Services
      • European Government
      • Natural Disasters
      • Not-for-Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Children-related news
      • Disabled Persons
      • Diversity, Equity & Inclusion
      • Hispanic-oriented news
      • LGBTQ+
      • Religion
      • Senior Citizens
      • Veterans
      • Women-Related news
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring Home
  • Send a Release
    • Chat

    • ALL CONTACT INFO
    • Contact Us


  • News Releases
  • Send a Release
  • Data Privacy
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • News Releases
  • Send a Release
  • Data Privacy
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • News Releases
  • Send a Release
  • Data Privacy
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • News Releases
  • Send a Release
  • Data Privacy

Beyond Injections: S-CELL Unveils Breakthrough "Endogenous GLP-1" Formula Powered by Akkermansia P9 Signaling and CoreBiome® Technology


News provided by

S-CELL

26 Jun, 2026, 14:42 CST

Share this article

Share toX

Share this article

Share toX

HONG KONG, June 26, 2026 /PRNewswire/ -- S-CELL, a premier innovator in cellular health and anti-aging biotechnology, today announced the launch of its advanced metabolic support synbiotic (Prebiotic and Probiotic) supplement. This pioneering formula represents a paradigm shift in weight management, and focuses on naturally stimulating the body's own production of GLP-1 (Glucagon-like peptide-1).

The gut microbiome is the foundation of health. For example, the immune system, brain, heart, bones, muscles and skin are all influenced by our gut microbes.[1] Indeed, gut health can influence your mood, skin, hair, and even sleep! Bottom line: gut health = human health.

The Science of Natural Satiety

As the global demand for GLP-1 based therapies surges, consumers are increasingly seeking non-pharmaceutical, healthy alternatives. S-CELL's new product addresses this need by leveraging the gut-metabolic axis.

"Our mission has always been to unlock the regenerative potential within our cells," said a spokesperson for S-CELL. "We believe the future of metabolic health lies not in replacing the body's hormones, but in signaling the body to produce them naturally. This formula is designed to reactivate the dormant L-Cells in the gut."[2]

A Dual-Pathway Mechanism

The efficacy of S-CELL's new formula lies in its unique synergy between two scientifically validated ingredients,[3] targeting GLP-1 production through distinct pathways:

  1. The P9 Signal (Akkermansia muciniphila): Often cited as the "next-generation probiotic,"[4], [5] Akkermansia plays a crucial role in metabolic regulation. S-CELL harnesses this strain's ability to secrete Protein P9, a specific signaling molecule. P9 interacts with gut cells to trigger the secretion of GLP-1, effectively flipping the body's "metabolic switch."
  2. Direct Receptor Activation (CoreBiome®): To amplify this signal, the formula incorporates CoreBiome®, a patented postbiotic consisting of highly bioavailable tributyrin. Unlike standard butyrate which is often absorbed too early in digestion, CoreBiome® reaches the colon intact. CoreBiome® is the "better butyrate" for gut health because it has been shown to reach the colon in lower doses.[6] There, it stimulates receptors on L-Cells directly, fueling the synthesis of GLP-1 while simultaneously strengthening the gut barrier.

Comprehensive Metabolic Health

WHAT IS BUTYRATE? Butyrate is a short chain fatty acid (SCFA) produced in the colon from undigested portions of vegetables (aka fiber). Fiber from fruits and vegetables and the production of short chain fatty acids are fundamentally important, yet 95% of Americans do NOT eat adequate levels of fiber.  Yes, 95%! This problem is so profound that recently an entire scientific article titled "Closing America's Fiber Intake Gap" was written about just this topic.[7] So, what's the problem? Without adequate fiber and resistant starch, butyrate isn't produced and the gut lining becomes permeable. This means that bad bacteria can leak into the bloodstream and cause ill health.

Intestinal permeability, also known as "leaky gut", essentially means small gaps develop in the intestinal lining. These small gaps can allow bad, inflammatory bacteria or toxins to enter the bloodstream.[8] This is critically important because those bacteria can now enter the bloodstream and trigger an unhealthy inflammatory response throughout the body

By combining the P9 signaling pathway with direct L-Cell receptor stimulation, S-CELL provides a holistic solution that supports healthy blood sugar levels, manages appetite, and reduces systemic inflammation—a key driver of aging. This product serves as a powerful companion to S-CELL's existing range of NAD+ and NMN anti-aging supplements.

John Gong, CEO of Vitacell: This new cutting edge, science backed, all natural synbiotic, is arguably the most potent available today. It directly stimulates the L Cells that produce GLP1.[9] It is formulated to be the closest to GLP-1. It is also a perfect companion for any GLP-1 or weight loss medication.[10]

Availability The new S-CELL metabolic formula is manufactured in GMP-certified facilities in the USA, ensuring pharmaceutical-grade quality. It has US FDA Free Sale Certification[11] and now available for purchase globally via the S-CELL official website.

All ingredients are biotics directly absorbed in the gut, and made from natural occurring sources, produced in the USA.[12] The metabolic formula is manufactured in the USA in NSF certified cGMP facilities ensuring pharmaceutical grade quality.

About S-CELL S-CELL is a brand under VitaCell International Ltd, dedicated to prolonging healthspan through cellular optimization. By merging cutting-edge Western biotechnology with holistic wellness principles, S-CELL delivers premium supplements designed to reverse biological aging, extend healthspan and enhance vitality.

References:

1.

Studies Referenced in Claims Substantiation, Kelsey Olanoff, Jun 23, 2022

https://app.box.com/s/gv2llstl3djyuligp3yesu47uqtelvwx

2.

Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannopoulos, E., ... & Gribble, F. M. (2012). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes, 61(2), 364-371. https://doi.org/10.2337/db11-1019

3

Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannopoulos, E., ... & Gribble, F. M. (2012). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes, 61(2), 364-371. https://doi.org/10.2337/db11-1019

4

Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation

https://drc.bmj.com/content/8/1/e001319

5

A Novel Combination of Pre-, Pro-, and Postbiotics Demonstrates Protective Effects on Intestinal Permeability in an In Vitro Gut Barrier Model

https://pmc.ncbi.nlm.nih.gov/articles/PMC9194111/ 

6

Wächtershäuser, A., & Stein, J. (2000). Rationale for the luminal provision of butyrate in intestinal diseases. European Journal of Nutrition, 39(4), 164-171. (Demonstrates that standard butyrate is rapidly absorbed in the upper gastrointestinal tract, necessitating delivery systems like tributyrin to reach the colon intact).

7

Quagliani, D., & Felt-Gunderson, P. (2016). Closing America's Fiber Intake Gap. American Journal of Lifestyle Medicine, 11(1), 80-85

8

A Novel Combination of Pre-, Pro-, and Postbiotics Demonstrates Protective Effects on Intestinal Permeability in an In Vitro Gut Barrier Model

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194111

9

Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannopoulos, E., ... & Gribble, F. M. (2012). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes, 61(2), 364-371. https://doi.org/10.2337/db11-1019

10

The interaction of Akkermansia muciniphila with host-derived substances, bacteria and diets

PMCID: PMC8236039  PMID: 34125276

https://pmc.ncbi.nlm.nih.gov/articles/PMC8236039/

11

Certificate Unique ID: VMZQ-Y6AX

12

Certificate Unique ID: VMZQ-Y6AX

SOURCE S-CELL

Modal title

Contact Cision

  • General Inquiries
  • Request a Demo
  • Partnerships
  • Media Inquiries

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Careers
  • Accessibility Statement
  • APAC – Simplified Chinese
  • APAC
  • APAC - Traditional Chinese
  • Arabic
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
  • Vietnam

My Services

  • All New Releases
  • Platform

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
[email protected]
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
  • Accessibility
Copyright © 2026 Cision US Inc.